In a review of recent literature, a team of researchers from Kessler Foundation conclude that cognitive rehabilitation programs are efficacious in treating multiple sclerosis-related cognitive dysfunction, and urge clinicians ...
Aug 19, 2021
0
147
The number of people with a diagnosis of Huntington's disease (HD) in Northern Scotland has increased by almost 50% over the last 30 years according to a new University of Aberdeen study.
Jul 15, 2021
0
4
University of South Australia researchers have made a major breakthrough in the treatment of depression after stroke, using a high frequency brain stimulation device to improve low moods.
Dec 11, 2020
0
4
Researchers conducting a large international study of progressive multiple sclerosis (MS) examined the impact of the global outbreak of coronavirus disease 2019 (COVID-19) on their study participants. Compared with pre-COVID ...
Sep 2, 2020
0
6
Researchers at Kessler Foundation conducted a pilot study comparing the effects of mental fatigue on brain activation patterns in people with and without multiple sclerosis (MS). Their findings indicate significant differences ...
Jul 28, 2020
0
10
Biomarkers to support the diagnosis of frontotemporal lobar degeneration (FTLD) and to assess the severity and expected prognosis of the disease are needed. Neurofilament light chain (NfL) measured from a blood sample strongly ...
Jun 15, 2020
0
32
During the COVID-19 pandemic, patients with multiple sclerosis (MS) and their clinicians have had questions and concerns about whether immunotherapies for MS could influence risk for infection or lead to an unfavorable outcome.
Jun 12, 2020
0
2
Consistent signs of compromised inhibition found in a study of concussion sufferers were mirrored in separate tests on Canadian university football players. These findings open new doors to predicting the impact of the often ...
Apr 17, 2020
0
44
A recent study by a team of University at Buffalo researchers has found a link between fats in the blood and problems with the arteries in people with multiple sclerosis (MS).
Jan 17, 2020
0
86
Screening technology to catch Parkinson's disease in its earliest stages could be available within three years, following an agreement between RMIT University and start-up company Jesse Medical.
Nov 27, 2019
0
3
